Dr Christophe Willekens
- Spécialité
- Hématologue, expert myélome et leucémie
- Hôpital
- Gustave Roussy (Villejuif)
- Derniers articles
-
- Venetoclax-proteasome inhibitor-dexamethasone for unfit patients with blastic plasmacytoid dendritic cell neoplasm. (25 févr. 2025)
- Relevance, Risks, and Benefits of Early-Phases Clinical Trials Participations for Patients With Hematological Malignancies From 2008 to 2023. (1 janv. 2025)
- Circulating Proteins Associated with Anti-IL6 Receptor Therapeutic Resistance in the Sera of Patients with Severe COVID-19. (1 nov. 2024)
- CXCL8 secreted by immature granulocytes inhibits WT hematopoiesis in chronic myelomonocytic leukemia. (17 sept. 2024)
- RAS mutations in myeloid malignancies: revisiting old questions with novel insights and therapeutic perspectives. (24 avr. 2024)